Live
- Bad air: 106 shuttle buses, 60 extra Metro trips planned to make Delhiites give up cars
- WHO reports declining monkeypox cases in Congo
- CM Attends Kotideepotsavam on Kartika Purnima
- PKL Season 11: Raiding trio of Devank, Ayan, Sandeep help Patna Pirates rout Bengal Warriorz
- Food waste crisis fuels sustainable practices across APAC food & beverage industry: Report
- AI helps erase racist deed restrictions in California
- ATMIS completes third phase of troops' drawdown in Somalia
- PM Kisan Samman Nidhi scheme bringing smile to Nalanda farmers
- German economy forecast to lag eurozone growth until 2026
- CM Shinde orders stern action against hoarding of onions amid rising prices
COVID-19 pandemic strengthened Hyderabad's role as world's vaccine capital: KTR
Telangana Industries Minister KT Rama Rao (Image credit: Twitter)
Telangana Industries Minister KT Rama Rao on Monday lauded the contribution of Bharat Biotech which developed Covaxin to fight against coronavirus.
Telangana Industries Minister KT Rama Rao on Monday lauded the contribution of Bharat Biotech which developed Covaxin to fight against coronavirus.
"COVID-19 pandemic strengthened Hyderabad's role as vaccine capital of the world thanks to the efforts of Biological E, Indian Immunologicals and others in developing the vaccine," the minister said launching the 18th edition of BioAsia.
He said that Dr Reddy's and Hetero Pharma are also added to the global supply by manufacturing and distributing Russian vaccine Sputnik. Also, the aurobindo pharma is developing a world-class vaccine manufacturing facility with a capacity of 450 million doses, the minister added.
"The government would work to strengthen the pharma industry in Hyderabad and would also establish a bio-pharma scale up facility 'B-Hub' at Genome valley," KTR said adding that B-Hub will help Telangana and India in accelerating the growth of the biopharmaceutical sector.
He hoped that the state would emerge as the biopharmaceutical capital of India.
